AGAhmet Yigit Goktay

Ahmet Yigit Goktay

*This is an algorithmically generated author record based on publicly available information.

Ahmet Yigit Goktay has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Endovascular Treatment of Thrombosis and Embolism

    by Ahmet Yigit Goktay, Cagin Senturk

  • Open Access

    Use of Percutaneous Aspiration Thrombectomy vs. Anticoagulation Therapy to Treat Acute Iliofemoral Venous Thrombosis: 1-year Follow-up Results of a Randomised, Clinical Trial

    by Volkan Cakir, Aytac Gulcu, Emrah Akay, Ahmet E. Capar, Tugra Gencpinar, Banu Kucuk, Ozalp Karabay, A. Yigit Goktay

    The purpose of this study was to compare the efficacy of percutaneous aspiration thrombectomy (PAT) followed by standard anticoagulant therapy, with anticoagulation therapy alone, for the treatment of acute proximal lower extremity deep vein thrombosis. In this randomised, prospective study, 42 patients with acute proximal iliofemoral deep vein thrombosis documented via Doppler ultrasound examination, were separated into an interventional treatment group (16 males, 5 females, average age 51 years) and a medical treatment group (13 males, 8 females, average age 59 years). In the interventional group, PAT with large-lumen 9-F diameter catheterisation was applied, after initiation of standard anticoagulant therapy. Balloon angioplasty (n 19) and stent implementation (n: 14) were used to treat patients with residual stenosis (>50 %) after PAT. Prophylactic IVC filters were placed in two patients. The thrombus clearance status of the venous system was evaluated by venography. In both the medical and interventional groups, venous patency rates and clinical symptom scores were evaluated at months 1, 3, and 12 after treatment. Deep venous systems became totally cleared of thrombi in 12 patients treated with PAT. The venous patency rates in month 12 were 57.1 and 4.76 % in the interventional and medical treatment groups, respectively. A statistically significant improvement was observed in clinical symptom scores of the interventional group (PAT) with or without stenting (4.23 ± 0.51 before treatment; 0.81 ± 0.92 at month 12) compared with the medical treatment group (4.00 ± 0.63 before treatment; 2.43 ± 0.67 at month 12). During follow-up, four patients in the medical treatment and one in the interventional group developed pulmonary embolisms. For treatment of acute deep vein thrombosis, PAT with or without stenting is superior to anticoagulant therapy alone in terms of both ensuring venous patency and improving clinical symptoms. PAT is a safe, inexpensive, and easily performed method of endovascular treatment with a low rate of major complications. Our present findings and literature data suggest that PAT can be used as first-line treatment in proximal deep vein thrombosis patients, especially when thrombolytic treatment is contraindicated.


  • Open Access

    Ghrelin and adipokines as circulating markers of disease activity in patients with Takayasu arteritis

    by Hatice Yilmaz, Vedat Gerdan, Didem Kozaci, Dilek Solmaz, Servet Akar, Gercek Can, Aytac Gulcu, Yigit Goktay, Ismail Sari, Merih Birlik, et al.

    Introduction: The current markers of disease activity in Takayasu arteritis (TA) are insufficient for proper assessment. We investigated circulating levels of unacylated and acylated ghrelin, leptin and adiponectin and their relationships with disease activity in patients with TA. Methods: This study included 31 patients with TA and 32 sex-, age- and body mass index-matched healthy controls. Disease activity was assessed in TA patients using various tools, including Kerr's criteria, disease extent index-Takayasu, physician's global assessment, radiological parameters, and laboratory markers. Plasma unacylated and acylated ghrelin, and serum leptin and adiponectin levels were measured using an enzyme-linked immunosorbent assay. Results: Unacylated and acylated ghrelin levels were found to be significantly lower in TA patients than that in healthy controls. Patients with active disease had lower unacylated ghrelin levels than those with inactive disease and had lower acylated ghrelin levels than healthy controls. Ghrelin levels were negatively correlated with various parameters of disease activity. The leptin/ghrelin ratio was significantly higher in TA patients than controls. It was positively correlated with disease activity. There was a positive correlation between unacylated and acylated ghrelin and a negative correlation between leptin and ghrelin. There was no statistical difference in adiponectin levels between TA patients and controls. The radiological activity markers were positively correlated with other parameters of disease activity. Conclusions: This study suggests that plasma unacylated and acylated ghrelin levels may be useful in monitoring disease activity and planning treatment strategies for patients with TA. The serum leptin level and leptin/ghrelin ratio may also be used to help assess the disease activity.


  • Vascular Disorders of the Kidney

    by Ahmet Yigit Göktay, Gregory T. MacLennan

  • Improved computerized evaluation of abdominal aortic aneurysm

    by Semi̇h Utku, Hulusi̇ Baysal, Reyat Yilmaz, Aytaç Gülcü, Recep Alp Kut, Ahmet Yi̇ği̇t Göktay

    Accurate measurements of arterial anatomy are emerging as the most important determinants of endovascular abdominal aneurysm repair. It is quite difficult to define and measure arterial anatomy features quantitatively due to the complex structure of the aneurysm and insufficient visual feedback. During decision making, to assist operators in diagnosing abdominal aortic aneurysms, a specialized preprocessing Abdominal Aortic Aneurysm Measurement and Evaluation Tool (AMET) was developed. AMET provides visual interfaces with broad measurement capabilities to generate a 3D model of the aorta for a better diagnosis and accurate stent selection. The accuracy and usability of the tool was tested with a series of measurements that were carried out on a selected patient group. The obtained statistical results were evaluated and compared with the current applied method used by the radiodiagnostic department. Test results showed that the new introduced measurement and evaluation tool, AMET, has higher measurement quality compared to the conventional manual method.

  • Percutaneous Treatment of Congenital Splenic Cysts: Drainage and Sclerotherapy with Polidocanol

    by A. Yigit Goktay, Mustafa Secil, Mehmet Ali Ozcan, Oguz Dicle

    Congenital “true” splenic cysts are rare lesions. Therapeutic methods for the management of these lesions have been based on preserving splenic function due to the immunologic role of spleen. We report three different cases of congenital splenic cysts treated by percutaneous drainage and polidocanol sclerotherapy. This less invasive treatment appears to be safe and effective after 6 to 36 months of follow-up.


  • Percutaneous Treatment of Hydatid Liver Cysts in Children as a Primary Treatment: Long-term Results

    by Ahmet Yigit Goktay, Mustafa Secil, Aytac Gulcu, Munevver Hosgor, Irfan Karaca, Mustafa Olguner, Feza M. Akgur, Oguz Dicle